Seeking Alpha
Value, growth, long-term horizon, medium-term horizon
Profile| Send Message|
( followers)  

Wish you could get an inside peek at your favorite companies? One idea is to consider insider stock buying trends. With this idea in mind, we ran a screen.

We began by screening for stocks on winning streaks, measured by a persistence of days in which the stock outperformed the S&P 500 and little persistence of days in underperforming the index. We measured this by the ratio of the longest winning streak (in days) divided by the longest losing streak over the last month.

We then screened for those stocks with the confidence of their company insiders, such as members of the board and upper management, with significant net insider purchases over the last six months representing at least 2% of share float. Since most companies only have a handful of company insiders, net insider purchases representing 2% of share float is a big show of confidence in their employer's prospects.

(click to enlarge)

Tool provided by Kapitall.

Do you think these stocks will continue to win? Use this list as a starting point for your own analysis.

List sorted by win streak/lose streak ratio.

1. Repros Therapeutics Inc. (NASDAQ:RPRX): Market cap at $123.6M, most recent closing price at $8.26. Over the last six months, insiders were net buyers of 562,500 shares, which represents about 5.88% of the company's 9.57M share float. The stock's average daily alpha vs. the S&P500 index stands at 4.48% (measured close to close, over the last month). During this period, the longest winning streak lasted 7 days (i.e. the stock's daily returns outperformed the S&P 500 for 7 consecutive days). The longest losing streak lasted 1 day (i.e. a win streak / losing streak ratio of 7).

2. Genomic Health Inc. (NASDAQ:GHDX): Focuses on the development and global commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. Market cap at $1.02B, most recent closing price at $33.25. Over the last six months, insiders were net buyers of 2,890,046 shares, which represents about 10.43% of the company's 27.72M share float. The stock's average daily alpha vs. the S&P500 index stands at 1.29% (measured close to close, over the last month). During this period, the longest winning streak lasted 9 days (i.e. the stock's daily returns outperformed the S&P 500 for 9 consecutive days). The longest losing streak lasted 2 days (i.e. a win streak / losing streak ratio of 4.5).

3. Furiex Pharmaceuticals, Inc. (NASDAQ:FURX): Engages in the compound partnering business in the United States and Europe. Market cap at $199.4M, most recent closing price at $19.58. Over the last six months, insiders were net buyers of 865,193 shares, which represents about 12.82% of the company's 6.75M share float. The stock's average daily alpha vs. the S&P500 index stands at 2.% (measured close to close, over the last month). During this period, the longest winning streak lasted 8 days (i.e. the stock's daily returns outperformed the S&P 500 for 8 consecutive days). The longest losing streak lasted 2 days (i.e. a win streak / losing streak ratio of 4).

4. Spark Networks, Inc. (NYSEMKT:LOV): Provides online personals services in the United States and internationally. Market cap at $102.38M, most recent closing price at $4.97. Over the last six months, insiders were net buyers of 628,805 shares, which represents about 8.89% of the company's 7.07M share float. The stock's average daily alpha vs. the S&P500 index stands at 0.87% (measured close to close, over the last month). During this period, the longest winning streak lasted 6 days (i.e. the stock's daily returns outperformed the S&P 500 for 6 consecutive days). The longest losing streak lasted 2 days (i.e. a win streak / losing streak ratio of 3).

5. Pharmacyclics Inc. (NASDAQ:PCYC): Operates as a clinical-stage biopharmaceutical company focusing on developing and commercializing small-molecule drugs for the treatment of immune mediated disease and cancer. Market cap at $2.17B, most recent closing price at $30.81. Over the last six months, insiders were net buyers of 2,054,434 shares, which represents about 3.77% of the company's 54.51M share float. The stock's average daily alpha vs. the S&P500 index stands at 1.08% (measured close to close, over the last month). During this period, the longest winning streak lasted 5 days (i.e. the stock's daily returns outperformed the S&P 500 for 5 consecutive days). The longest losing streak lasted 2 days (i.e. a win streak / losing streak ratio of 2.5).

*Price data and insider data sourced from Yahoo! Finance, all other data sourced from Finviz.

Source: 5 Insider Stock Picks On Winning Streaks